Novo Nordisk AS
Kurs
Diff. Vortag in %
52 Wochen Tief
52 Wochen Hoch
- Neutral
- Seit dem 20.03.2026
- Informationen von thescreener.com
Tools
Fundamentalanalyse
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 239,60 270 | 239,60 | 270 | 12,805515 | JEFFERIES | ||
| Novo Nordisk AS | 23.03.2026 0 Monate | 23.03.2026 | 0 Monate | 239,60 270 | 239,60 | 270 | 12,805515 | BARCLAYS | ||
| Novo Nordisk AS | 11.03.2026 0 Monate | 11.03.2026 | 0 Monate | 239,60 300 | 239,60 | 300 | 25,339461 | BERENBERG | ||
| Novo Nordisk AS | 09.03.2026 0 Monate | 09.03.2026 | 0 Monate | 239,60 250 | 239,60 | 250 | 4,449551 | JPMORGAN | ||
| Novo Nordisk AS | 06.03.2026 12 Monate | 06.03.2026 | 12 Monate | 239,60 270 | 239,60 | 270 | 12,805515 | BARCLAYS | ||
| Novo Nordisk AS | 02.03.2026 12 Monate | 02.03.2026 | 12 Monate | 239,60 260 | 239,60 | 260 | 8,627533 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 02.03.2026 0 Monate | 02.03.2026 | 0 Monate | 239,60 270 | 239,60 | 270 | 12,805515 | BARCLAYS | ||
| Novo Nordisk AS | 27.02.2026 12 Monate | 27.02.2026 | 12 Monate | 239,60 270 | 239,60 | 270 | 12,805515 | BARCLAYS | ||
| Novo Nordisk AS | 24.02.2026 12 Monate | 24.02.2026 | 12 Monate | 239,60 400 | 239,60 | 400 | 67,119281 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.02.2026 0 Monate | 24.02.2026 | 0 Monate | 239,60 250 | 239,60 | 250 | 4,449551 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 239,60 400 | 239,60 | 400 | 67,119281 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 239,60 332 | 239,60 | 332 | 38,709004 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 239,60 340 | 239,60 | 340 | 42,051389 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 239,60 275 | 239,60 | 275 | 14,894506 | JEFFERIES | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 239,60 350 | 239,60 | 350 | 46,229371 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 239,60 340 | 239,60 | 340 | 42,051389 | BARCLAYS | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 239,60 275 | 239,60 | 275 | 14,894506 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 23.02.2026 0 Monate | 23.02.2026 | 0 Monate | 239,60 250 | 239,60 | 250 | 4,449551 | JPMORGAN | ||
| Novo Nordisk AS | 23.02.2026 12 Monate | 23.02.2026 | 12 Monate | 239,60 270 | 239,60 | 270 | 12,805515 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 239,60 340 | 239,60 | 340 | 42,051389 | BARCLAYS | ||
| Novo Nordisk AS | 18.02.2026 0 Monate | 18.02.2026 | 0 Monate | 239,60 340 | 239,60 | 340 | 42,051389 | BARCLAYS | ||
| Novo Nordisk AS | 17.02.2026 0 Monate | 17.02.2026 | 0 Monate | 239,60 340 | 239,60 | 340 | 42,051389 | BARCLAYS | ||
| Novo Nordisk AS | 12.02.2026 0 Monate | 12.02.2026 | 0 Monate | 239,60 340 | 239,60 | 340 | 42,051389 | BARCLAYS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 239,60 400 | 239,60 | 400 | 67,119281 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 239,60 275 | 239,60 | 275 | 14,894506 | JEFFERIES | ||
| Novo Nordisk AS | 11.02.2026 0 Monate | 11.02.2026 | 0 Monate | 239,60 360 | 239,60 | 360 | 50,407353 | BERENBERG | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 239,60 360 | 239,60 | 360 | 50,407353 | BARCLAYS | ||
| Novo Nordisk AS | 09.02.2026 0 Monate | 09.02.2026 | 0 Monate | 239,60 360 | 239,60 | 360 | 50,407353 | BARCLAYS | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 239,60 350 | 239,60 | 350 | 46,229371 | JPMORGAN | ||
| Novo Nordisk AS | 06.02.2026 0 Monate | 06.02.2026 | 0 Monate | 239,60 332 | 239,60 | 332 | 38,709004 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 239,60 475 | 239,60 | 475 | 98,454147 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 239,60 332 | 239,60 | 332 | 38,709004 | UBS | ||
| Novo Nordisk AS | 05.02.2026 0 Monate | 05.02.2026 | 0 Monate | 239,60 350 | 239,60 | 350 | 46,229371 | JPMORGAN | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 239,60 270 | 239,60 | 270 | 12,805515 | JEFFERIES | ||
| Novo Nordisk AS | 03.02.2026 0 Monate | 03.02.2026 | 0 Monate | 239,60 350 | 239,60 | 350 | 46,229371 | JPMORGAN | ||
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 239,60 350 | 239,60 | 350 | 46,229371 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 02.02.2026 0 Monate | 02.02.2026 | 0 Monate | 239,60 360 | 239,60 | 360 | 50,407353 | BARCLAYS | ||
| Novo Nordisk AS | 01.02.2026 0 Monate | 01.02.2026 | 0 Monate | 239,60 390 | 239,60 | 390 | 62,941299 | UBS | ||
| Novo Nordisk AS | 29.01.2026 0 Monate | 29.01.2026 | 0 Monate | 239,60 350 | 239,60 | 350 | 46,229371 | JPMORGAN | ||
| Novo Nordisk AS | 23.01.2026 12 Monate | 23.01.2026 | 12 Monate | 239,60 270 | 239,60 | 270 | 12,805515 | JEFFERIES | ||
| Novo Nordisk AS | 22.01.2026 12 Monate | 22.01.2026 | 12 Monate | 239,60 436 | 239,60 | 436 | 82,160017 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 22.01.2026 0 Monate | 22.01.2026 | 0 Monate | 239,60 415 | 239,60 | 415 | 73,386254 | BERENBERG | ||
| Novo Nordisk AS | 21.01.2026 12 Monate | 21.01.2026 | 12 Monate | 239,60 360 | 239,60 | 360 | 50,407353 | BARCLAYS | ||
| Novo Nordisk AS | 20.01.2026 12 Monate | 20.01.2026 | 12 Monate | 239,60 270 | 239,60 | 270 | 12,805515 | JEFFERIES | ||
| Novo Nordisk AS | 20.01.2026 0 Monate | 20.01.2026 | 0 Monate | 239,60 390 | 239,60 | 390 | 62,941299 | UBS | ||
| Novo Nordisk AS | 19.01.2026 0 Monate | 19.01.2026 | 0 Monate | 239,60 390 | 239,60 | 390 | 62,941299 | UBS | ||
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 239,60 360 | 239,60 | 360 | 50,407353 | BARCLAYS | ||
| Novo Nordisk AS | 15.01.2026 0 Monate | 15.01.2026 | 0 Monate | 239,60 415 | 239,60 | 415 | 73,386254 | BERENBERG |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 15.01.2026 12 Monate | 15.01.2026 | 12 Monate | 239,60 475 | 239,60 | 475 | 98,454147 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 239,60 350 | 239,60 | 350 | 46,229371 | JPMORGAN | ||
| Novo Nordisk AS | 14.01.2026 0 Monate | 14.01.2026 | 0 Monate | 239,60 390 | 239,60 | 390 | 62,941299 | UBS | ||
| Novo Nordisk AS | 09.01.2026 12 Monate | 09.01.2026 | 12 Monate | 239,60 400 | 239,60 | 400 | 67,119281 | BERENBERG | ||
| Novo Nordisk AS | 07.01.2026 12 Monate | 07.01.2026 | 12 Monate | 239,60 400 | 239,60 | 400 | 67,119281 | BERENBERG | ||
| Novo Nordisk AS | 06.01.2026 12 Monate | 06.01.2026 | 12 Monate | 239,60 360 | 239,60 | 360 | 50,407353 | BARCLAYS | ||
| Novo Nordisk AS | 02.01.2026 0 Monate | 02.01.2026 | 0 Monate | 239,60 350 | 239,60 | 350 | 46,229371 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 239,60 475 | 239,60 | 475 | 98,454147 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 16.12.2025 12 Monate | 16.12.2025 | 12 Monate | 239,60 350 | 239,60 | 350 | 46,229371 | JPMORGAN | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 239,60 475 | 239,60 | 475 | 98,454147 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 12.12.2025 0 Monate | 12.12.2025 | 0 Monate | 239,60 295 | 239,60 | 295 | 23,25047 | UBS | ||
| Novo Nordisk AS | 11.12.2025 0 Monate | 11.12.2025 | 0 Monate | 239,60 295 | 239,60 | 295 | 23,25047 | UBS |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 239,60 350 | 239,60 | 350 | 46,229371 | JPMORGAN | ||
| Novo Nordisk AS | 08.12.2025 12 Monate | 08.12.2025 | 12 Monate | 239,60 352 | 239,60 | 352 | 47,064968 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 04.12.2025 0 Monate | 04.12.2025 | 0 Monate | 239,60 400 | 239,60 | 400 | 67,119281 | BERENBERG | ||
| Novo Nordisk AS | 03.12.2025 0 Monate | 03.12.2025 | 0 Monate | 239,60 295 | 239,60 | 295 | 23,25047 | UBS | ||
| Novo Nordisk AS | 30.11.2025 0 Monate | 30.11.2025 | 0 Monate | 239,60 270 | 239,60 | 270 | 12,805515 | JEFFERIES | ||
| Novo Nordisk AS | 28.11.2025 12 Monate | 28.11.2025 | 12 Monate | 239,60 375 | 239,60 | 375 | 56,674326 | BARCLAYS | ||
| Novo Nordisk AS | 28.11.2025 0 Monate | 28.11.2025 | 0 Monate | 239,60 315 | 239,60 | 315 | 31,606434 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 239,60 475 | 239,60 | 475 | 98,454147 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 26.11.2025 12 Monate | 26.11.2025 | 12 Monate | 239,60 353 | 239,60 | 353 | 47,482766 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 239,60 475 | 239,60 | 475 | 98,454147 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 25.11.2025 0 Monate | 25.11.2025 | 0 Monate | 239,60 500 | 239,60 | 500 | 108,899102 | JPMORGAN | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 239,60 500 | 239,60 | 500 | 108,899102 | JPMORGAN |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 239,60 290 | 239,60 | 290 | 21,161479 | JEFFERIES | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 239,60 375 | 239,60 | 375 | 56,674326 | BARCLAYS | ||
| Novo Nordisk AS | 24.11.2025 12 Monate | 24.11.2025 | 12 Monate | 239,60 391 | 239,60 | 391 | 63,359098 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 24.11.2025 0 Monate | 24.11.2025 | 0 Monate | 239,60 | 239,60 | -- | DZ BANK | |||
| Novo Nordisk AS | 17.11.2025 0 Monate | 17.11.2025 | 0 Monate | 239,60 315 | 239,60 | 315 | 31,606434 | UBS | ||
| Novo Nordisk AS | 13.11.2025 0 Monate | 13.11.2025 | 0 Monate | 239,60 400 | 239,60 | 400 | 67,119281 | BERENBERG | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 239,60 475 | 239,60 | 475 | 98,454147 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 239,60 600 | 239,60 | 600 | 150,678922 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 10.11.2025 12 Monate | 10.11.2025 | 12 Monate | 239,60 | 239,60 | -- | DZ BANK | |||
| Novo Nordisk AS | 10.11.2025 0 Monate | 10.11.2025 | 0 Monate | 239,60 315 | 239,60 | 315 | 31,606434 | UBS | ||
| Novo Nordisk AS | 07.11.2025 0 Monate | 07.11.2025 | 0 Monate | 239,60 315 | 239,60 | 315 | 31,606434 | UBS | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 239,60 600 | 239,60 | 600 | 150,678922 | DEUTSCHE BANK RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 239,60 391 | 239,60 | 391 | 63,359098 | GOLDMAN SACHS | ||
| Novo Nordisk AS | 06.11.2025 0 Monate | 06.11.2025 | 0 Monate | 239,60 540 | 239,60 | 540 | 125,61103 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 239,60 290 | 239,60 | 290 | 21,161479 | JEFFERIES | ||
| Novo Nordisk AS | 06.11.2025 12 Monate | 06.11.2025 | 12 Monate | 239,60 500 | 239,60 | 500 | 108,899102 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 12 Monate | 05.11.2025 | 12 Monate | 239,60 500 | 239,60 | 500 | 108,899102 | JPMORGAN | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 239,60 290 | 239,60 | 290 | 21,161479 | JEFFERIES | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 239,60 340 | 239,60 | 340 | 42,051389 | UBS | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 239,60 540 | 239,60 | 540 | 125,61103 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 05.11.2025 0 Monate | 05.11.2025 | 0 Monate | 239,60 315 | 239,60 | 315 | 31,606434 | UBS | ||
| Novo Nordisk AS | 04.11.2025 0 Monate | 04.11.2025 | 0 Monate | 239,60 540 | 239,60 | 540 | 125,61103 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 12 Monate | 12 Monate | 239,60 600 | 239,60 | 600 | 150,678922 | DEUTSCHE BANK RESEARCH | |||
| Novo Nordisk AS | 30.10.2025 0 Monate | 30.10.2025 | 0 Monate | 239,60 540 | 239,60 | 540 | 125,61103 | BERNSTEIN RESEARCH |
| Aktie | Datum Zeitraum | Datum | Zeitraum | Akt. Kurs Kursziel | Akt. Kurs | Kursziel | Abstand in % | Analyst | Bew. | Bewertung |
|---|---|---|---|---|---|---|---|---|---|---|
| Novo Nordisk AS | 24.10.2025 0 Monate | 24.10.2025 | 0 Monate | 239,60 290 | 239,60 | 290 | 21,161479 | JEFFERIES | ||
| Novo Nordisk AS | 22.10.2025 12 Monate | 22.10.2025 | 12 Monate | 239,60 600 | 239,60 | 600 | 150,678922 | DEUTSCHE BANK RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 239,60 540 | 239,60 | 540 | 125,61103 | BERNSTEIN RESEARCH | ||
| Novo Nordisk AS | 21.10.2025 0 Monate | 21.10.2025 | 0 Monate | 239,60 340 | 239,60 | 340 | 42,051389 | UBS |
News
Aktuell
| Datum | Terminart Information | Information |
|---|---|---|
| 26.03.2026 | Ordentliche Hauptversammlung Novo Nordisk A/S: Annual General Meeting 2026 | Novo Nordisk A/S: Annual General Meeting 2026 |
| 06.05.2026 | Bericht zum 1. Quartal Novo Nordisk A/S: First quarter 2026 | Novo Nordisk A/S: First quarter 2026 |
| 05.08.2026 | Bericht zum 2. Quartal Novo Nordisk A/S: Second quarter 2026 | Novo Nordisk A/S: Second quarter 2026 |
Novo Nordisk: mehr als nur Abnehmspritzen – die Chance nach dem Kursrutsch?
Der dänische Pharmakonzern Novo Nordisk dominiert mit den Blockbustern Ozempic und Wegovy (Wirkstoff Semaglutid) den milliardenschweren Markt für Diabetes- und Adipositas-Medikamente. Jüngste Gewinnwarnungen, wachsende Konkurrenz (insbesondere durch Eli Lilly) und regulatorische Unsicherheiten (Nachahmerpräparate, Preisdruck) haben die Aktie stark unter Druck gebracht.
DZ BANK Produktauswahl
Discount Classic
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Short
Produktauswahl : Basiswert Novo Nordisk AS
Optionsscheine Classic Long
Produktauswahl : Basiswert Novo Nordisk AS
Endlos Turbos Long
Produktauswahl : Basiswert Novo Nordisk AS
Mini-Futures Short
Produktauswahl : Basiswert Novo Nordisk AS
Knock Out Map
- wertpapiere@dzbank.de (069) 7447-7035
-
DZ BANK AG, Platz der Republik,
60265 Frankfurt / M